Bhattacharya R, Herren K, Poonawalla I, Bunniran S, Bloomfield A, Schwab PE. Comparing medical utilization and cost outcomes in oral versus injectable immunotherapy users with chronic inflammatory joint and skin diseases. J Manag Care Spec Pharm. 2020 Oct;26(10):1246-56. doi: 10.18553/jmcp.2020.26.10.1246
Bowe A, Poonawalla I, Tindal M, Meah Y, Schwab P. Cardiovascular outcomes with Dulaglutide vs. Liraglutide. Poster presented at the 80th American Diabetes Association Scientific Sessions; June 13, 2020.
Poonawalla I, Bowe A, Tindal M, Meah Y, Schwab P. SGLT2 inhibitors: comparative effectiveness of SGLT2 inhibitors vs GLP1 agonists. Presented at the 80th American Diabetes Association Scientific Sessions; June 12, 2020.
Schwab P, Poonawalla I, Bowe A, Tindal M, Meah Y. SGLT2 inhibitors: a comparison of cardiovascular, medical and cost outcomes. Presented at the 80th American Diabetes Association Scientific Sessions; June 12, 2020.